Polypharmacy in the elderly: Can comprehensive geriatric assessment reduce inappropriate medication use?

Drugs and Aging

Volumn 28, Issue 7, 2011, Pages 509-518

  Sergi, Giuseppe ^a,b   De Rui, Marina ^a   Sarti, Silvia ^a   Manzato, Enzo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Clinica Geriatrica Ospedale Giustinianeo (2 Piano)   (Italy)

Author keywords

Drug utilisation; Elderly; Prescribing

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BENZODIAZEPINE DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GASTROINTESTINAL AGENT; GASTROPROTECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PROTECTIVE AGENT; SEDATIVE AGENT; UNCLASSIFIED DRUG; WARFARIN;

AGED; BLEEDING; CARDIOVASCULAR SYMPTOM; CLINICAL ASSESSMENT; COGNITION; COMORBIDITY; COMPREHENSIVE GERIATRIC ASSESSMENT; ECONOMIC ASPECT; FALLING; FRAIL ELDERLY; FUNCTIONAL STATUS; GASTROINTESTINAL SYMPTOM; GERIATRIC ASSESSMENT; HIP FRACTURE; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; MENTAL DISEASE; MUSCLE MASS; NUTRITIONAL STATUS; PATIENT COMPLIANCE; PATIENT MOBILITY; PATIENT PREFERENCE; PHYSICAL PERFORMANCE; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SIDE EFFECT; SOCIAL SUPPORT; SWALLOWING; TERMINALLY ILL PATIENT; VASCULAR ACCESS; VISUAL IMPAIRMENT;

AGED; GERIATRIC ASSESSMENT; HUMANS; MEDICATION ADHERENCE; POLYPHARMACY;

EID: 79959946206     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11592010-000000000-00000     Document Type: Review

References (57)

1. Hovstadius B, Hovstadius K, Astrand B, et al. Increasing polypharmacy: an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 2010; 10: 16
2. Haider SI, Johnell K, Thorslund M, et al. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002. Int J Clin Pharmacol Ther 2007 Dec; 45 (12): 643-53
3. Marengoni A, Rizzuto D, Wang HX, et al. Patterns of chronic multimorbidity in the elderly population. J Am Geriatr Soc 2009 Feb; 57 (2): 225-30
4. Franceschi M, Scarcelli C, Niro V, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008; 31 (6): 545-56 (Pubitemid 351693687)
5. Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol 2001 Jun; 51 (6): 615-22 (Pubitemid 32862751)
6. Rubenstein LZ, Josephson KR, Wieland GD, et al. Effectiveness of a geriatric evaluation unit: a randomized clinical trial. N Engl J Med 1984 Dec 27; 311 (26): 1664-70 (Pubitemid 15183997)
7. Stuck AE, Aronow HU, Steiner A, et al. A trial of annual in-home comprehensive geriatric assessments for elderly people living in the community. N Engl JMed 1995 Nov 2; 333 (18): 1184-9
8. Tulner LR, van Campen JP, Frankfort SV, et al. Changes in under-treatment after comprehensive geriatric assessment: an observational study. Drugs Aging 2010 Oct 1; 27 (10): 831-43
9. Lampela P, Hartikainen S, Lavikainen P, et al. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a populationbased intervention study. Drugs Aging 2010 Jun 1; 27 (6): 507-21
10. Bjerrum L, Sgaard J, Hallas J, et al. Polypharmacy: correlations with sex, age and drug regimen: a prescription database study. Eur J Clin Pharmacol 1998May; 54 (3): 197-202
11. JyrkkäJ, Enlund H, Korhonen MJ, et al. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging 2009; 26 (6): 493-503
12. Crentsil V, Ricks MO, Xue QL, et al. A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmacother 2010 Jun; 8 (3): 215-24
13. Harugeri A, Joseph J, Parthasarathi G, et al. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: a prospective surveillance study from two teaching hospitals in India. Am J Geriatr Pharmacother 2010 Jun; 8 (3): 271-80
14. Dwyer LL, Han B, Woodwell DA, et al. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother 2010 Feb; 8 (1): 63-72
15. Lapi F, Pozzi C, Mazzaglia G, et al. Epidemiology of suboptimal prescribing in older, community-dwellers: a two wave, population-based survey in Dicomano, Italy. Drugs Aging 2009; 26 (12): 1029-38
16. Corsonello A, Pedone C, Corica F, et al. Polypharmacy in elderly patients at discharge from the acute care hospital. Ther Clin Risk Manag 2007 Mar; 3 (1): 197-203 (Pubitemid 46671835)
17. Fillenbaum GG, Horner RD, Hanlon JT, et al. Factors predicting change in prescription and nonprescription drug use in a community-residing black and white elderly population. J Clin Epidemiol 1996 May; 49 (5): 587-93 (Pubitemid 26195615)
18. Tinetti ME, Bogardus Jr ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004 Dec 30; 351 (27): 2870-4
19. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005 Aug 10; 294 (6): 716-24 (Pubitemid 41159291)
20. Mansur N, Weiss A, Beloosesky Y. Relationship of in-hospital medication modifications of elderly patients to postdischarge medications, adherence, and mortality. Ann Pharmacother 2008 Jun; 42 (6): 783-9 (Pubitemid 351778086)
21. Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007 Feb; 63 (2): 187-95 (Pubitemid 46072105)
22. Corsonello A, Pedone C, Corica F, et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005 Apr 11; 165 (7): 790-5 (Pubitemid 40569433)
23. Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006 May; 61 (5): 511-5 (Pubitemid 43794712)
24. Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001 Jul 9; 161 (13): 1629-34 (Pubitemid 32681144)
25. Nguyen JK, Fouts MM, Kotabe SE, et al. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006 Mar; 4 (1): 36-41
26. Gnjidic D, Le Couteur DG, Abernethy DR, et al. Drug Burden Index and Beers Criteria: impact on functional outcomes in older people living in self-care retirement villages. J Clin Pharmacol. Epub 2011 Feb 2
27. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001 May-Jun; 31 (4): 199-205 (Pubitemid 32592646)
28. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002 Dec; 50 (12): 1962-8 (Pubitemid 35462441)
29. Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001 Nov; 77 (913): 703-7 (Pubitemid 33016070)
30. Rochon PA, Gurwitz JH. Drug therapy. Lancet 1995 Jul 1; 346 (8966): 32-6
31. Lai SW, Liao KF, Liao CC, et al. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population- based study. Medicine (Baltimore) 2010 Sep; 89 (5): 295-9
32. Haleem S, Lutchman L, Mayahi R, et al. Mortality following hip fracture: trends and geographical variations over the last 40 years. Injury 2008 Oct; 39 (10): 1157-63
33. Ziere G, Dieleman JP, Hofman A, et al. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol 2006 Feb; 61 (2): 218-23 (Pubitemid 43382615)
34. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001 Aug; 23 (8): 1296-310 (Pubitemid 32804122)
35. Di Bari M, Balzi D, Roberts AT, et al. Prognostic stratification of older persons based on simple administrative data: development and validation of the Silver Code, to be used in emergency department triage. JGerontol A Biol Sci Med Sci 2010 Feb; 65 (2): 159-64
36. Rubenstein LZ, Abrass IB, Kane RL. Improved care for patients on a new geriatric evaluation unit. J Am Geriatr Soc 1981 Nov; 29 (11): 531-6 (Pubitemid 12252073)
37. Sergi G, Perissinotto E, Pisent C, et al., ILSA Working Group. An adequate threshold for body mass index to detect underweight condition in elderly persons: the Italian Longitudinal Study on Aging (ILSA). J Gerontol A Biol Sci Med Sci 2005 Jul; 60 (7): 866-71 (Pubitemid 41098631)
38. Pilotto A, Ferrucci L, Franceschi M, et al. Development and validation of a multidimensional prognostic index for oneyear mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res 2008; 11 (1): 151-61 (Pubitemid 351271625)
39. Pilotto A, Addante F, Ferrucci L, et al. The multidimensional prognostic index predicts short- and longterm mortality in hospitalized geriatric patients with pneumonia. J Gerontol A Biol Sci Med Sci 2009 Aug; 64 (8): 880-7
40. Pilotto A, Addante F, Franceschi M, et al. Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail 2010 Jan; 3 (1): 14-20
41. Kuijpers MA, van Marum RJ, Egberts AC, et al. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008 Jan; 65 (1): 130-3 (Pubitemid 350265160)
42. Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006 Oct; 54 (10): 1516-23 (Pubitemid 44564145)
43. Rochon PA, Gurwitz JH. Prescribing for seniors: neither too much nor too little. JAMA 1999 Jul 14; 282 (2): 113-5 (Pubitemid 29323789)
44. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994 Mar 3; 330 (9): 592-6 (Pubitemid 24065792)
45. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991 Sep; 151 (9): 1825-32
46. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts [published erratum appears in Arch Intern Med 2004 Feb 9; 164 (3): 298]. Arch Intern Med 2003 Dec 8-22; 163 (22): 2716-24
47. Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992 Oct; 45 (10): 1045-51
48. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment): Consensus validation. Int J Clin Pharmacol Ther 2008 Feb; 46 (2): 72-83 (Pubitemid 351233792)
49. George CJ, Jacobs LG. Geriatrics medication management rounds: a novel approach to teaching rational prescribing with the use of the medication screening questionnaire. J Am Geriatr Soc 2011 Jan; 59 (1): 138-42. Epub 2011 Jan 3
50. Walsh EK, Cussen K. Take ten minutes: a dedicated ten minute medication review reduces polypharmacy in the elderly. Ir Med J 2010 Sep; 103 (8): 236-8
51. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: how well are states closing the gap? Health Aff (Millwood) 2002 Jul-Dec; Suppl. Web Exclusives: W253-68 (Pubitemid 41542369)
52. Doggrell SA. Adherence to medicines in the older-aged with chronic conditions: does intervention by an allied health professional help? Drugs Aging 2010 Mar 1; 27 (3): 239-54
53. Rich MW, Gray DB, Beckham V, et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am JMed 1996 Sep; 101 (3): 270-6 (Pubitemid 26392440)
54. Wu JY, Leung WY, Chang S, et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006 Sep 9; 333 (7567): 522
55. Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006 Mar 27; 166 (6): 605-9
56. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007 Jun; 9 (6): 430-4 (Pubitemid 46979143)
57. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010 Oct 11; 170 (18): 1648-54